Cullinan Therapeutics (CGEM) executive compensation, 2026 proxy

Nadim Ahmed, President and Chief Executive Officer, was paid $5.1M in 2025, down 34% from $7.7M the year before.

Filed
April 28, 2026
Annual meeting
June 16, 2026
Pay year
2025
Named executives
3
CEO total pay
$5.1M-34% vs prior year
CEO pay in equity
77%$3.9M in awards
CEO 2025 Total Pay
$5,100,006Decrease from prior year
CEO Base Salary Increase
3.50%Effective in 2025
CEO Target Bonus
60%Of base salary in 2025

How Ahmed was paid

$5.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary14%Stock awards33%Option awards44%Non-equity incentive8%All other compensation1%

Named executive officers

ExecutiveTotal
Nadim AhmedPresident and Chief Executive Officer$5,100,006
Jeffrey Jones, M.D.Chief Medical Officer$2,221,578
Mary Kay FentonChief Financial Officer$2,078,837

What changed and why

  • $5.1MCEO Nadim Ahmed received total compensation of $5,100,006 in 2025, representing a decrease from $7,684,366 in 2024.
  • 3.50%Base salaries for named executive officers increased by 3.50% for 2025.
  • 60%Mr. Ahmed's annual target cash bonus increased to 60% of his base salary in 2025.
  • Named executive officers received annual equity grants consisting of stock options and restricted stock units on February 19, 2025.
  • Compensia served as compensation consultant until June 2025, after which Pay Governance was engaged.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.